113 related articles for article (PubMed ID: 30463110)
1. [RHAMM (receptor hyaluronan-mediated motility)-target peptides induce apoptosis in prostate cancer cells].
Akentieva NP; Shushanov SS
Vopr Onkol; 2016; 62(3):514-8. PubMed ID: 30463110
[TBL] [Abstract][Full Text] [Related]
2. Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells.
Akent'eva NP; Shushanov SS; Kotel'nikov AI
Bull Exp Biol Med; 2015 Sep; 159(5):658-61. PubMed ID: 26459475
[TBL] [Abstract][Full Text] [Related]
3. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
4. RHAMM splice variants confer radiosensitivity in human breast cancer cell lines.
Schütze A; Vogeley C; Gorges T; Twarock S; Butschan J; Babayan A; Klein D; Knauer SK; Metzen E; Müller V; Jendrossek V; Pantel K; Milde-Langosch K; Fischer JW; Röck K
Oncotarget; 2016 Apr; 7(16):21428-40. PubMed ID: 26870892
[TBL] [Abstract][Full Text] [Related]
5. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells.
Fukui M; Ueno K; Suehiro Y; Hamanaka Y; Imai K; Hinoda Y
Cancer Immunol Immunother; 2006 May; 55(5):538-46. PubMed ID: 16025267
[TBL] [Abstract][Full Text] [Related]
8. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
[TBL] [Abstract][Full Text] [Related]
9. Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM).
Ziebell MR; Prestwich GD
J Comput Aided Mol Des; 2004 Oct; 18(10):597-614. PubMed ID: 15849992
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
11. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
12. RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.
Gust KM; Hofer MD; Perner SR; Kim R; Chinnaiyan AM; Varambally S; Moller P; Rinnab L; Rubin MA; Greiner J; Schmitt M; Kuefer R; Ringhoffer M
Neoplasia; 2009 Sep; 11(9):956-63. PubMed ID: 19724689
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
[TBL] [Abstract][Full Text] [Related]
15. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.
Assmann V; Marshall JF; Fieber C; Hofmann M; Hart IR
J Cell Sci; 1998 Jun; 111 ( Pt 12)():1685-94. PubMed ID: 9601098
[TBL] [Abstract][Full Text] [Related]
16. RB Loss Promotes Prostate Cancer Metastasis.
Thangavel C; Boopathi E; Liu Y; Haber A; Ertel A; Bhardwaj A; Addya S; Williams N; Ciment SJ; Cotzia P; Dean JL; Snook A; McNair C; Price M; Hernandez JR; Zhao SG; Birbe R; McCarthy JB; Turley EA; Pienta KJ; Feng FY; Dicker AP; Knudsen KE; Den RB
Cancer Res; 2017 Feb; 77(4):982-995. PubMed ID: 27923835
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of RHAMM-target peptides on invasion of breast cancer cells].
Akentieva NP; Shushanov SS
Vopr Onkol; 2016; 62(6):831-8. PubMed ID: 30702238
[TBL] [Abstract][Full Text] [Related]
18. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue.
Korkes F; de Castro MG; de Cassio Zequi S; Nardi L; Del Giglio A; de Lima Pompeo AC
BJU Int; 2014 May; 113(5):822-9. PubMed ID: 24053431
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants.
Crainie M; Belch AR; Mant MJ; Pilarski LM
Blood; 1999 Mar; 93(5):1684-96. PubMed ID: 10029598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]